<?xml version="1.0" encoding="UTF-8"?>

<Bundle xmlns="http://hl7.org/fhir">
  <id value="5bb930aa-f30d-4f10-aeef-e85f6b5f8d59"/>
  <meta>
    <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-bundle"/>
  </meta>
  <type value="collection"/>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPMedicinalProductDefinition/Estalis-Transdermalpatch"/>
    <resource>
      <MedicinalProductDefinition>
        <id value="Estalis-Transdermalpatch"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-medicinalproductdefinition"/>
        </meta>
        <text>
          <status value="extensions"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_Estalis-Transdermalpatch"> </a><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition Estalis-Transdermalpatch</b></p><a name="Estalis-Transdermalpatch"> </a><a name="hcEstalis-Transdermalpatch"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-medicinalproductdefinition.html">IDMP MedicinalProductDefinition</a></p></div><p><b>CH - SMC Authorized Dose Form</b>: <span title="Codes:{http://standardterms.edqm.eu 10519000}">Transdermal patch</span></p><p><b>identifier</b>: <a href="NamingSystem-MPID.html" title="Temporary Identifier in this implementation guide until officially released by Swissmedic">Medical Product Identifier</a>/CH-7601001029439-5470402</p><p><b>indication</b>: </p><div><p>Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.
Osteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.</p>
</div><p><b>legalStatusOfSupply</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply 756005022003}">Medicinal product subject to medical or veterinary prescription (B)</span></p><p><b>additionalMonitoringIndicator</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator 756005001003}">No Warning</span></p><p><b>pediatricUseIndicator</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator 756005003002}">Not authorised for the treatment in children</span></p><p><b>classification</b>: <span title="Codes:{http://www.whocc.no/atc G03FA01}">norethisterone and estrogen</span>, <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category 756005021001}">NA KAS art. 12 para. 5 TPLO</span>, <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode 756005004001}">Synthetic</span>, <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type 756001003002}">Originator product</span></p><p><b>attachedDocument</b>: </p><ul><li><a href="DocumentReference-DocRef-FI-Estalis.html">DocumentReference: identifier = http://fhir.ch/ig/ch-epl/sid/attno#Application / Assessment Tracking Number#123456789-initial submission-Example-hij-123; status = current; type = Fachinformation; date = 2021-10-01 00:00:00+0000</a></li><li><a href="DocumentReference-DocRef-PI-Estalis.html">DocumentReference: identifier = http://fhir.ch/ig/ch-epl/sid/attno#Application / Assessment Tracking Number#123456789-initial submission-Example-hij-321; status = current; type = Patienteninformation; date = 2021-10-01 00:00:00+0000</a></li></ul><blockquote><p><b>name</b></p><p><b>productName</b>: ESTALIS Matrixpfl 50/250 24 Stk</p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type SMC}">Zugelassener Arzneimittelname</span></p><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{urn:iso:std:iso:3166 CH}">Switzerland</span></td><td><span title="Codes:{urn:ietf:bcp:47 de-CH}">German (Switzerland)</span></td></tr></table></blockquote></div>
        </text>
        <extension url="http://fhir.ch/ig/ch-epl/StructureDefinition/authorizedDoseForm">
          <valueCodeableConcept>
            <coding>
              <system value="http://standardterms.edqm.eu"/>
              <code value="10519000"/>
              <display value="Transdermal patch"/>
            </coding>
          </valueCodeableConcept>
        </extension>
        <identifier>
          <system value="http://fhir.ch/ig/ch-epl/sid/mpid"/>
          <value value="CH-7601001029439-5470402"/>
        </identifier>
        <indication value="Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.&#xA;Osteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden."/>
        <legalStatusOfSupply>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply"/>
            <code value="756005022003"/>
            <display value="Medicinal product subject to medical or veterinary prescription (B)"/>
          </coding>
        </legalStatusOfSupply>
        <additionalMonitoringIndicator>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator"/>
            <code value="756005001003"/>
            <display value="No Warning"/>
          </coding>
        </additionalMonitoringIndicator>
        <pediatricUseIndicator>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator"/>
            <code value="756005003002"/>
            <display value="Not authorised for the treatment in children"/>
          </coding>
        </pediatricUseIndicator>
        <classification>
          <coding>
            <system value="http://www.whocc.no/atc"/>
            <code value="G03FA01"/>
          </coding>
        </classification>
        <classification>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category"/>
            <code value="756005021001"/>
            <display value="NA KAS art. 12 para. 5 TPLO"/>
          </coding>
        </classification>
        <classification>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode"/>
            <code value="756005004001"/>
            <display value="Synthetic"/>
          </coding>
        </classification>
        <classification>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type"/>
            <code value="756001003002"/>
            <display value="Originator product"/>
          </coding>
        </classification>
        <attachedDocument>
          <reference value="DocumentReference/DocRef-FI-Estalis"/>
        </attachedDocument>
        <attachedDocument>
          <reference value="DocumentReference/DocRef-PI-Estalis"/>
        </attachedDocument>
        <name>
          <productName value="ESTALIS Matrixpfl 50/250 24 Stk"/>
          <type>
            <coding>
              <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type"/>
              <code value="SMC"/>
              <display value="Zugelassener Arzneimittelname"/>
            </coding>
          </type>
          <usage>
            <country>
              <coding>
                <system value="urn:iso:std:iso:3166"/>
                <code value="CH"/>
                <display value="Switzerland"/>
              </coding>
            </country>
            <language>
              <coding>
                <system value="urn:ietf:bcp:47"/>
                <code value="de-CH"/>
                <display value="German (Switzerland)"/>
              </coding>
            </language>
          </usage>
        </name>
      </MedicinalProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPDocumentReference/DocRef-FI-Estalis"/>
    <resource>
      <DocumentReference>
        <id value="DocRef-FI-Estalis"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-documentreference"/>
        </meta>
        <language value="de-CH"/>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml" xml:lang="de-CH" lang="de-CH"><a name="DocumentReference_DocRef-FI-Estalis"> </a><p class="res-header-id"><b>Generated Narrative: DocumentReference DocRef-FI-Estalis</b></p><a name="DocRef-FI-Estalis"> </a><a name="hcDocRef-FI-Estalis"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: de-CH</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-documentreference.html">CH IDMP DocumentReference</a></p></div><p><b>identifier</b>: <a href="NamingSystem-AttNo.html" title="Temporary Namingsystem in this implementation guide until officially released by Swissmedic">Application / Assessment Tracking Number</a>/123456789-initial submission-Example-hij-123</p><p><b>status</b>: Current</p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type 756005007001}">Fachinformation</span></p><p><b>date</b>: 2021-10-01 00:00:00+0000</p><blockquote><p><b>content</b></p><h3>Attachments</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Url</b></td></tr><tr><td style="display: none">*</td><td><a href="https://swissmedicinfo.ch/showTextAccepted.aspx?textType=FI&amp;lang=DE&amp;authNr=54704&amp;supportMultipleResults=1">https://swissmedicinfo.ch/showTextAccepted.aspx?textType=FI&amp;lang=DE&amp;authNr=54704&amp;supportMultipleResults=1</a></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <system value="http://fhir.ch/ig/ch-epl/sid/attno"/>
          <value value="123456789-initial submission-Example-hij-123"/>
        </identifier>
        <status value="current"/>
        <type>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type"/>
            <code value="756005007001"/>
            <display value="Fachinformation"/>
          </coding>
        </type>
        <date value="2021-10-01T00:00:00Z"/>
        <content>
          <attachment>
            <url value="https://swissmedicinfo.ch/showTextAccepted.aspx?textType=FI&amp;lang=DE&amp;authNr=54704&amp;supportMultipleResults=1"/>
          </attachment>
        </content>
      </DocumentReference>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPDocumentReference/DocRef-PI-Estalis"/>
    <resource>
      <DocumentReference>
        <id value="DocRef-PI-Estalis"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-documentreference"/>
        </meta>
        <language value="de-CH"/>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml" xml:lang="de-CH" lang="de-CH"><a name="DocumentReference_DocRef-PI-Estalis"> </a><p class="res-header-id"><b>Generated Narrative: DocumentReference DocRef-PI-Estalis</b></p><a name="DocRef-PI-Estalis"> </a><a name="hcDocRef-PI-Estalis"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: de-CH</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-documentreference.html">CH IDMP DocumentReference</a></p></div><p><b>identifier</b>: <a href="NamingSystem-AttNo.html" title="Temporary Namingsystem in this implementation guide until officially released by Swissmedic">Application / Assessment Tracking Number</a>/123456789-initial submission-Example-hij-321</p><p><b>status</b>: Current</p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type 756005007002}">Patienteninformation</span></p><p><b>date</b>: 2021-10-01 00:00:00+0000</p><blockquote><p><b>content</b></p><h3>Attachments</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Url</b></td></tr><tr><td style="display: none">*</td><td><a href="https://swissmedicinfo.ch/showTextAccepted.aspx?textType=PI&amp;lang=DE&amp;authNr=54704&amp;supportMultipleResults=1">https://swissmedicinfo.ch/showTextAccepted.aspx?textType=PI&amp;lang=DE&amp;authNr=54704&amp;supportMultipleResults=1</a></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <system value="http://fhir.ch/ig/ch-epl/sid/attno"/>
          <value value="123456789-initial submission-Example-hij-321"/>
        </identifier>
        <status value="current"/>
        <type>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type"/>
            <code value="756005007002"/>
            <display value="Patienteninformation"/>
          </coding>
        </type>
        <date value="2021-10-01T00:00:00Z"/>
        <content>
          <attachment>
            <url value="https://swissmedicinfo.ch/showTextAccepted.aspx?textType=PI&amp;lang=DE&amp;authNr=54704&amp;supportMultipleResults=1"/>
          </attachment>
        </content>
      </DocumentReference>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPRegulatedAuthorisation/MA-5470402"/>
    <resource>
      <RegulatedAuthorization>
        <id value="MA-5470402"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_MA-5470402"> </a><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization MA-5470402</b></p><a name="MA-5470402"> </a><a name="hcMA-5470402"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-regulatedauthorization.html">IDMP RegulatedAuthorization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-AuthNo.html" title="Temporary Identifier in this implementation guide until officially released by Swissmedic">Marketing Authorisation Number</a>/5470402</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Estalis-Transdermalpatch.html">MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-7601001029439-5470402; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.
Osteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type 756000002001}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{urn:iso:std:iso:3166 CH}">Switzerland</span></p><p><b>status</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status 756005023007}">valid</span></p><p><b>statusDate</b>: 1999-08-17</p><p><b>holder</b>: <a href="#hcMA-5470402/holder-Sandoz-Pharmaceuticals-AG">Organization Sandoz Pharmaceuticals AG</a></p><p><b>regulator</b>: <a href="#hcMA-5470402/regulator-SMC">Organization SMC</a></p><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #holder-Sandoz-Pharmaceuticals-AG</b></p><a name="MA-5470402/holder-Sandoz-Pharmaceuticals-AG"> </a><a name="hcMA-5470402/holder-Sandoz-Pharmaceuticals-AG"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-epl-organization.html">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-LOC.html" title="Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)">LOC Identifier</a>/100054743, <a href="NamingSystem-GLN.html" title="Identifier holding a number for GLN (Global Location Number)">GLN Identifier</a>/7601001029439</p><p><b>name</b>: Sandoz Pharmaceuticals AG</p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #regulator-SMC</b></p><a name="MA-5470402/regulator-SMC"> </a><a name="hcMA-5470402/regulator-SMC"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-epl-organization.html">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-LOC.html" title="Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)">LOC Identifier</a>/100010911, <a href="NamingSystem-GLN.html" title="Identifier holding a number for GLN (Global Location Number)">GLN Identifier</a>/7601001398511</p><p><b>name</b>: SMC</p></blockquote></div>
        </text>
        <contained>
          <Organization>
            <id value="holder-Sandoz-Pharmaceuticals-AG"/>
            <meta>
              <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"/>
            </meta>
            <identifier>
              <system value="urn:oid:1.2.276.0.76"/>
              <value value="100054743"/>
            </identifier>
            <identifier>
              <system value="urn:oid:2.51.1.3"/>
              <value value="7601001029439"/>
            </identifier>
            <name value="Sandoz Pharmaceuticals AG"/>
          </Organization>
        </contained>
        <contained>
          <Organization>
            <id value="regulator-SMC"/>
            <meta>
              <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"/>
            </meta>
            <identifier>
              <system value="urn:oid:1.2.276.0.76"/>
              <value value="100010911"/>
            </identifier>
            <identifier>
              <system value="urn:oid:2.51.1.3"/>
              <value value="7601001398511"/>
            </identifier>
            <name value="SMC"/>
          </Organization>
        </contained>
        <identifier>
          <system value="http://fhir.ch/ig/ch-epl/sid/authno"/>
          <value value="5470402"/>
        </identifier>
        <subject>
          <reference value="MedicinalProductDefinition/Estalis-Transdermalpatch"/>
        </subject>
        <type>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type"/>
            <code value="756000002001"/>
            <display value="Marketing Authorisation"/>
          </coding>
        </type>
        <region>
          <coding>
            <system value="urn:iso:std:iso:3166"/>
            <code value="CH"/>
            <display value="Switzerland"/>
          </coding>
        </region>
        <status>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status"/>
            <code value="756005023007"/>
            <display value="valid"/>
          </coding>
        </status>
        <statusDate value="1999-08-17"/>
        <holder>
          <reference value="#holder-Sandoz-Pharmaceuticals-AG"/>
        </holder>
        <regulator>
          <reference value="#regulator-SMC"/>
        </regulator>
      </RegulatedAuthorization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPPackagedProductDefinition/PMP-Estalis-Transdermalpatch"/>
    <resource>
      <PackagedProductDefinition>
        <id value="PMP-Estalis-Transdermalpatch"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-packagedproductdefinition"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_PMP-Estalis-Transdermalpatch"> </a><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition PMP-Estalis-Transdermalpatch</b></p><a name="PMP-Estalis-Transdermalpatch"> </a><a name="hcPMP-Estalis-Transdermalpatch"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-packagedproductdefinition.html">IDMP PackagedProductDefinition</a></p></div><p><b>identifier</b>: <a href="NamingSystem-PCID.html" title="Temporary Identifier in this implementation guide until officially released by Swissmedic">Clinical Product Identifier</a>/CH-7601001029439-5470402-097</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-Estalis-Transdermalpatch.html">MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-7601001029439-5470402; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.
Osteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><p><b>containedItemQuantity</b>: 24 Patch<span style="background: LightGoldenRodYellow"> (Details: EDQM - Standard Terms  code15036000 = 'Patch')</span></p><p><b>description</b>: </p><div><p>ESTALIS Matrixpfl 50/250 24 Stk</p>
</div><h3>LegalStatusOfSupplies</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply 756005022003}">Medicinal product subject to medical or veterinary prescription (B)</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <a href="NamingSystem-GTIN.html" title="GS1 defines trade items as products or services that are priced, ordered or invoiced at any point in the supply chain.">Global Trade Item Number</a>/7680547040979</p><p><b>type</b>: <span title="Codes:{http://standardterms.edqm.eu 30009000}">Box</span></p><p><b>quantity</b>: 1</p><h3>ShelfLifeStorages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Period[x]</b></td><td><b>SpecialPrecautionsForStorage</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://spor.ema.europa.eu/v1/lists/100000073343 100000073403}">Shelf life of the medicinal product as packaged for sale</span></td><td>No display for Duration  (value: 6; unit: month; system: http://unitsofmeasure.org; code: mo)</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-special-precautions-for-storage 756005042004}">protect from light</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <system value="http://fhir.ch/ig/ch-epl/sid/pcid"/>
          <value value="CH-7601001029439-5470402-097"/>
        </identifier>
        <packageFor>
          <reference value="MedicinalProductDefinition/Estalis-Transdermalpatch"/>
        </packageFor>
        <containedItemQuantity>
          <value value="24"/>
          <unit value="Patch"/>
          <system value="http://standardterms.edqm.eu"/>
          <code value="15036000"/>
        </containedItemQuantity>
        <description value="ESTALIS Matrixpfl 50/250 24 Stk"/>
        <legalStatusOfSupply>
          <code>
            <coding>
              <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply"/>
              <code value="756005022003"/>
              <display value="Medicinal product subject to medical or veterinary prescription (B)"/>
            </coding>
          </code>
        </legalStatusOfSupply>
        <packaging>
          <identifier>
            <system value="urn:oid:2.51.1.1"/>
            <value value="7680547040979"/>
          </identifier>
          <type>
            <coding>
              <system value="http://standardterms.edqm.eu"/>
              <code value="30009000"/>
              <display value="Box"/>
            </coding>
          </type>
          <quantity value="1"/>
          <shelfLifeStorage>
            <type>
              <coding>
                <system value="http://spor.ema.europa.eu/v1/lists/100000073343"/>
                <code value="100000073403"/>
                <display value="Shelf life of the medicinal product as packaged for sale"/>
              </coding>
            </type>
            <periodDuration>
              <value value="6"/>
              <unit value="month"/>
              <system value="http://unitsofmeasure.org"/>
              <code value="mo"/>
            </periodDuration>
            <specialPrecautionsForStorage>
              <coding>
                <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-special-precautions-for-storage"/>
                <code value="756005042004"/>
                <display value="protect from light"/>
              </coding>
            </specialPrecautionsForStorage>
          </shelfLifeStorage>
        </packaging>
      </PackagedProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPRegulatedAuthorisation/MA-54704089"/>
    <resource>
      <RegulatedAuthorization>
        <id value="MA-54704089"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_MA-54704089"> </a><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization MA-54704089</b></p><a name="MA-54704089"> </a><a name="hcMA-54704089"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-regulatedauthorization.html">IDMP RegulatedAuthorization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-AuthNo.html" title="Temporary Identifier in this implementation guide until officially released by Swissmedic">Marketing Authorisation Number</a>/54704089</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Estalis-Transdermalpatch.html">MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-7601001029439-5470402; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.
Osteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type 756000002001}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{urn:iso:std:iso:3166 CH}">Switzerland</span></p><p><b>status</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status 756005023007}">valid</span></p><p><b>statusDate</b>: 1999-08-17</p><p><b>holder</b>: <a href="#hcMA-54704089/holder-Sandoz-Pharmaceuticals-AG">Organization Sandoz Pharmaceuticals AG</a></p><p><b>regulator</b>: <a href="#hcMA-54704089/regulator-SMC">Organization SMC</a></p><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #holder-Sandoz-Pharmaceuticals-AG</b></p><a name="MA-54704089/holder-Sandoz-Pharmaceuticals-AG"> </a><a name="hcMA-54704089/holder-Sandoz-Pharmaceuticals-AG"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-epl-organization.html">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-LOC.html" title="Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)">LOC Identifier</a>/100054743, <a href="NamingSystem-GLN.html" title="Identifier holding a number for GLN (Global Location Number)">GLN Identifier</a>/7601001029439</p><p><b>name</b>: Sandoz Pharmaceuticals AG</p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #regulator-SMC</b></p><a name="MA-54704089/regulator-SMC"> </a><a name="hcMA-54704089/regulator-SMC"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-epl-organization.html">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-LOC.html" title="Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)">LOC Identifier</a>/100010911, <a href="NamingSystem-GLN.html" title="Identifier holding a number for GLN (Global Location Number)">GLN Identifier</a>/7601001398511</p><p><b>name</b>: SMC</p></blockquote></div>
        </text>
        <contained>
          <Organization>
            <id value="holder-Sandoz-Pharmaceuticals-AG"/>
            <meta>
              <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"/>
            </meta>
            <identifier>
              <system value="urn:oid:1.2.276.0.76"/>
              <value value="100054743"/>
            </identifier>
            <identifier>
              <system value="urn:oid:2.51.1.3"/>
              <value value="7601001029439"/>
            </identifier>
            <name value="Sandoz Pharmaceuticals AG"/>
          </Organization>
        </contained>
        <contained>
          <Organization>
            <id value="regulator-SMC"/>
            <meta>
              <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"/>
            </meta>
            <identifier>
              <system value="urn:oid:1.2.276.0.76"/>
              <value value="100010911"/>
            </identifier>
            <identifier>
              <system value="urn:oid:2.51.1.3"/>
              <value value="7601001398511"/>
            </identifier>
            <name value="SMC"/>
          </Organization>
        </contained>
        <identifier>
          <system value="http://fhir.ch/ig/ch-epl/sid/authno"/>
          <value value="54704089"/>
        </identifier>
        <subject>
          <reference value="MedicinalProductDefinition/Estalis-Transdermalpatch"/>
        </subject>
        <type>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type"/>
            <code value="756000002001"/>
            <display value="Marketing Authorisation"/>
          </coding>
        </type>
        <region>
          <coding>
            <system value="urn:iso:std:iso:3166"/>
            <code value="CH"/>
            <display value="Switzerland"/>
          </coding>
        </region>
        <status>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status"/>
            <code value="756005023007"/>
            <display value="valid"/>
          </coding>
        </status>
        <statusDate value="1999-08-17"/>
        <holder>
          <reference value="#holder-Sandoz-Pharmaceuticals-AG"/>
        </holder>
        <regulator>
          <reference value="#regulator-SMC"/>
        </regulator>
      </RegulatedAuthorization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPRegulatedAuthorisation/FOPH-17418"/>
    <resource>
      <RegulatedAuthorization>
        <id value="FOPH-17418"/>
        <text>
          <status value="extensions"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_FOPH-17418"> </a><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization FOPH-17418</b></p><a name="FOPH-17418"> </a><a name="hcFOPH-17418"> </a><blockquote><p><b>CH - EPL Reimbursement SL</b></p><ul><li>FOPHDossierNumber: <a href="NamingSystem-Dossier.html" title="Identifier holding the Dossier number of FOPH">FOPH Dossier Number</a>/17418</li><li>status: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-reimbursement-status 756001021001}">Reimbursed</span></li><li>statusDate: 2000-04-15</li><li>listingStatus: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-listing-status 756001002001}">Listed</span></li><li>listingPeriod: 2000-04-15 --&gt; (ongoing)</li><li>firstListingDate: 2000-04-15</li><li>costShare: 10</li><li>gamme: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-gamme 756002004011}">Transdermal</span></li></ul></blockquote><blockquote><p><b>CH - EPL Product Price</b></p><ul><li>value: <span title="Swiss Franc">CHF32.44</span> (CHF)</li><li>type: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type 756002005002}">Ex-factory price</span></li><li>changeType: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change 756002006007}">Price mutation after triennal review of pharmaceuticals</span></li><li>changeDate: 2014-11-01</li></ul></blockquote><blockquote><p><b>CH - EPL Product Price</b></p><ul><li>value: <span title="Swiss Franc">CHF53.65</span> (CHF)</li><li>type: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type 756002005001}">Retail price</span></li><li>changeType: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change 756002006005}">VAT-change</span></li><li>changeDate: 2024-01-01</li></ul></blockquote><p><b>subject</b>: <a href="PackagedProductDefinition-PMP-Estalis-Transdermalpatch.html">PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-epl/sid/pcid#Clinical Product Identifier#CH-7601001029439-5470402-097; containedItemQuantity = 24 Patch; description = ESTALIS Matrixpfl 50/250 24 Stk</a></p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type 756000002003}">Reimbursement SL</span></p><h3>Indications</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Extension</b></td><td><b>Reference</b></td></tr><tr><td style="display: none">*</td><td/><td><a href="ClinicalUseDefinition-IND-10031285.html">ClinicalUseDefinition: type = indication</a></td></tr></table><p><b>holder</b>: <a href="#hcFOPH-17418/holder-Sandoz-Pharmaceuticals-AG">Organization Sandoz Pharmaceuticals AG</a></p><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #holder-Sandoz-Pharmaceuticals-AG</b></p><a name="FOPH-17418/holder-Sandoz-Pharmaceuticals-AG"> </a><a name="hcFOPH-17418/holder-Sandoz-Pharmaceuticals-AG"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-epl-organization.html">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href="NamingSystem-LOC.html" title="Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)">LOC Identifier</a>/100054743, <a href="NamingSystem-GLN.html" title="Identifier holding a number for GLN (Global Location Number)">GLN Identifier</a>/7601001029439</p><p><b>name</b>: Sandoz Pharmaceuticals AG</p></blockquote></div>
        </text>
        <contained>
          <Organization>
            <id value="holder-Sandoz-Pharmaceuticals-AG"/>
            <meta>
              <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"/>
            </meta>
            <identifier>
              <system value="urn:oid:1.2.276.0.76"/>
              <value value="100054743"/>
            </identifier>
            <identifier>
              <system value="urn:oid:2.51.1.3"/>
              <value value="7601001029439"/>
            </identifier>
            <name value="Sandoz Pharmaceuticals AG"/>
          </Organization>
        </contained>
        <extension url="http://fhir.ch/ig/ch-epl/StructureDefinition/reimbursementSL">
          <extension url="FOPHDossierNumber">
            <valueIdentifier>
              <system value="urn:oid:2.16.756.1"/>
              <value value="17418"/>
            </valueIdentifier>
          </extension>
          <extension url="status">
            <valueCodeableConcept>
              <coding>
                <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-reimbursement-status"/>
                <code value="756001021001"/>
                <display value="Reimbursed"/>
              </coding>
            </valueCodeableConcept>
          </extension>
          <extension url="statusDate">
            <valueDate value="2000-04-15"/>
          </extension>
          <extension url="listingStatus">
            <valueCodeableConcept>
              <coding>
                <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-listing-status"/>
                <code value="756001002001"/>
                <display value="Listed"/>
              </coding>
            </valueCodeableConcept>
          </extension>
          <extension url="listingPeriod">
            <valuePeriod>
              <start value="2000-04-15"/>
            </valuePeriod>
          </extension>
          <extension url="firstListingDate">
            <valueDate value="2000-04-15"/>
          </extension>
          <extension url="costShare">
            <valueInteger value="10"/>
          </extension>
          <extension url="gamme">
            <valueCodeableConcept>
              <coding>
                <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-gamme"/>
                <code value="756002004011"/>
                <display value="Transdermal"/>
              </coding>
            </valueCodeableConcept>
          </extension>
        </extension>
        <extension url="http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice">
          <extension url="value">
            <valueMoney>
              <value value="32.44"/>
              <currency value="CHF"/>
            </valueMoney>
          </extension>
          <extension url="type">
            <valueCodeableConcept>
              <coding>
                <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type"/>
                <code value="756002005002"/>
                <display value="Ex-factory price"/>
              </coding>
            </valueCodeableConcept>
          </extension>
          <extension url="changeType">
            <valueCodeableConcept>
              <coding>
                <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change"/>
                <code value="756002006007"/>
                <display value="Price mutation after triennal review of pharmaceuticals"/>
              </coding>
            </valueCodeableConcept>
          </extension>
          <extension url="changeDate">
            <valueDate value="2014-11-01"/>
          </extension>
        </extension>
        <extension url="http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice">
          <extension url="value">
            <valueMoney>
              <value value="53.65"/>
              <currency value="CHF"/>
            </valueMoney>
          </extension>
          <extension url="type">
            <valueCodeableConcept>
              <coding>
                <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type"/>
                <code value="756002005001"/>
                <display value="Retail price"/>
              </coding>
            </valueCodeableConcept>
          </extension>
          <extension url="changeType">
            <valueCodeableConcept>
              <coding>
                <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change"/>
                <code value="756002006005"/>
                <display value="VAT-change"/>
              </coding>
            </valueCodeableConcept>
          </extension>
          <extension url="changeDate">
            <valueDate value="2024-01-01"/>
          </extension>
        </extension>
        <subject>
          <reference value="PackagedProductDefinition/PMP-Estalis-Transdermalpatch"/>
        </subject>
        <type>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type"/>
            <code value="756000002003"/>
            <display value="Reimbursement SL"/>
          </coding>
        </type>
        <indication>
          <extension url="http://fhir.ch/ig/ch-epl/StructureDefinition/regulatedAuthorization-limitation">
            <extension url="status">
              <valueCodeableConcept>
                <coding>
                  <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-limitationstatus"/>
                  <code value="756002071001"/>
                  <display value="Limitation Reimbursed"/>
                </coding>
              </valueCodeableConcept>
            </extension>
            <extension url="statusDate">
              <valueDate value="2000-04-15"/>
            </extension>
            <extension url="period">
              <valuePeriod>
                <start value="2000-04-15"/>
              </valuePeriod>
            </extension>
            <extension url="firstLimitationDate">
              <valueDate value="2000-04-15"/>
            </extension>
            <extension url="http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice">
              <extension url="value">
                <valueMoney>
                  <value value="32.44"/>
                  <currency value="CHF"/>
                </valueMoney>
              </extension>
              <extension url="type">
                <valueCodeableConcept>
                  <coding>
                    <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type"/>
                    <code value="756002005002"/>
                    <display value="Ex-factory price"/>
                  </coding>
                </valueCodeableConcept>
              </extension>
              <extension url="changeType">
                <valueCodeableConcept>
                  <coding>
                    <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change"/>
                    <code value="756002006007"/>
                    <display value="Price mutation after triennal review of pharmaceuticals"/>
                  </coding>
                </valueCodeableConcept>
              </extension>
              <extension url="changeDate">
                <valueDate value="2014-11-01"/>
              </extension>
            </extension>
            <extension url="http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice">
              <extension url="value">
                <valueMoney>
                  <value value="53.65"/>
                  <currency value="CHF"/>
                </valueMoney>
              </extension>
              <extension url="type">
                <valueCodeableConcept>
                  <coding>
                    <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type"/>
                    <code value="756002005001"/>
                    <display value="Retail price"/>
                  </coding>
                </valueCodeableConcept>
              </extension>
              <extension url="changeType">
                <valueCodeableConcept>
                  <coding>
                    <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change"/>
                    <code value="756002006005"/>
                    <display value="VAT-change"/>
                  </coding>
                </valueCodeableConcept>
              </extension>
              <extension url="changeDate">
                <valueDate value="2024-01-01"/>
              </extension>
            </extension>
          </extension>
          <reference>
            <reference value="ClinicalUseDefinition/IND-10031285"/>
          </reference>
        </indication>
        <holder>
          <reference value="#holder-Sandoz-Pharmaceuticals-AG"/>
        </holder>
      </RegulatedAuthorization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPManufacturedItemDefinition/MI-Estradiolum-Norethisteroni-Transdermalpatch"/>
    <resource>
      <ManufacturedItemDefinition>
        <id value="MI-Estradiolum-Norethisteroni-Transdermalpatch"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-manufactureditemdefinition"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_MI-Estradiolum-Norethisteroni-Transdermalpatch"> </a><p class="res-header-id"><b>Generated Narrative: ManufacturedItemDefinition MI-Estradiolum-Norethisteroni-Transdermalpatch</b></p><a name="MI-Estradiolum-Norethisteroni-Transdermalpatch"> </a><a name="hcMI-Estradiolum-Norethisteroni-Transdermalpatch"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-manufactureditemdefinition.html">CH IDMP ManufacturedItemDefinition</a></p></div><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title="Codes:{http://standardterms.edqm.eu 10519000}">Transdermal patch</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{http://standardterms.edqm.eu 15036000}">Patch</span></p></div>
        </text>
        <status value="active"/>
        <manufacturedDoseForm>
          <coding>
            <system value="http://standardterms.edqm.eu"/>
            <code value="10519000"/>
            <display value="Transdermal patch"/>
          </coding>
        </manufacturedDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="http://standardterms.edqm.eu"/>
            <code value="15036000"/>
            <display value="Patch"/>
          </coding>
        </unitOfPresentation>
      </ManufacturedItemDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPAdministrableProductDefinition/PhP-Estradiolum-Norethisteroni-Transdermalpatch"/>
    <resource>
      <AdministrableProductDefinition>
        <id value="PhP-Estradiolum-Norethisteroni-Transdermalpatch"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-administrableproductdefinition"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="AdministrableProductDefinition_PhP-Estradiolum-Norethisteroni-Transdermalpatch"> </a><p class="res-header-id"><b>Generated Narrative: AdministrableProductDefinition PhP-Estradiolum-Norethisteroni-Transdermalpatch</b></p><a name="PhP-Estradiolum-Norethisteroni-Transdermalpatch"> </a><a name="hcPhP-Estradiolum-Norethisteroni-Transdermalpatch"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-administrableproductdefinition.html">CH IDMP AdministrableProductDefinition</a></p></div><p><b>status</b>: Active</p><p><b>formOf</b>: <a href="MedicinalProductDefinition-Estalis-Transdermalpatch.html">MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-7601001029439-5470402; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.
Osteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><p><b>administrableDoseForm</b>: <span title="Codes:{http://standardterms.edqm.eu 10519000}">Transdermal patch</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{http://standardterms.edqm.eu 15036000}">Patch</span></p><h3>RouteOfAdministrations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://standardterms.edqm.eu 20070000}">Transdermal use</span></td></tr></table></div>
        </text>
        <status value="active"/>
        <formOf>
          <reference value="MedicinalProductDefinition/Estalis-Transdermalpatch"/>
        </formOf>
        <administrableDoseForm>
          <coding>
            <system value="http://standardterms.edqm.eu"/>
            <code value="10519000"/>
            <display value="Transdermal patch"/>
          </coding>
        </administrableDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="http://standardterms.edqm.eu"/>
            <code value="15036000"/>
            <display value="Patch"/>
          </coding>
        </unitOfPresentation>
        <routeOfAdministration>
          <code>
            <coding>
              <system value="http://standardterms.edqm.eu"/>
              <code value="20070000"/>
              <display value="Transdermal use"/>
            </coding>
          </code>
        </routeOfAdministration>
      </AdministrableProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPClinicalUseDefinition/IND-10030247"/>
    <resource>
      <ClinicalUseDefinition>
        <id value="IND-10030247"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-clinicalusedefinition-indication"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_IND-10030247"> </a><p class="res-header-id"><b>Generated Narrative: ClinicalUseDefinition IND-10030247</b></p><a name="IND-10030247"> </a><a name="hcIND-10030247"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-clinicalusedefinition-indication.html">CH IDMP ClinicalUseDefinition Indication</a></p></div><p><b>type</b>: Indication</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Estalis-Transdermalpatch.html">MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-7601001029439-5470402; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.
Osteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><blockquote><p><b>indication</b></p><h3>DiseaseSymptomProcedures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://www.meddra.org 10030247}">Oestrogenmangel</span></td></tr></table><h3>Comorbidities</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://www.meddra.org 10027308}">Menopause</span></td></tr></table><h3>IntendedEffects</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://spor.ema.europa.eu/v1/lists/200000003186 200000003192}">preventive</span></td></tr></table></blockquote></div>
        </text>
        <type value="indication"/>
        <subject>
          <reference value="MedicinalProductDefinition/Estalis-Transdermalpatch"/>
        </subject>
        <indication>
          <diseaseSymptomProcedure>
            <concept>
              <coding>
                <system value="https://www.meddra.org"/>
                <code value="10030247"/>
                <display value="Oestrogenmangel"/>
              </coding>
            </concept>
          </diseaseSymptomProcedure>
          <comorbidity>
            <concept>
              <coding>
                <system value="https://www.meddra.org"/>
                <code value="10027308"/>
                <display value="Menopause"/>
              </coding>
            </concept>
          </comorbidity>
          <intendedEffect>
            <concept>
              <coding>
                <system value="http://spor.ema.europa.eu/v1/lists/200000003186"/>
                <code value="200000003192"/>
                <display value="preventive"/>
              </coding>
            </concept>
          </intendedEffect>
        </indication>
      </ClinicalUseDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPClinicalUseDefinition/IND-10031285"/>
    <resource>
      <ClinicalUseDefinition>
        <id value="IND-10031285"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-clinicalusedefinition-indication"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_IND-10031285"> </a><p class="res-header-id"><b>Generated Narrative: ClinicalUseDefinition IND-10031285</b></p><a name="IND-10031285"> </a><a name="hcIND-10031285"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-clinicalusedefinition-indication.html">CH IDMP ClinicalUseDefinition Indication</a></p></div><p><b>type</b>: Indication</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Estalis-Transdermalpatch.html">MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-7601001029439-5470402; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.
Osteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><blockquote><p><b>indication</b></p><h3>DiseaseSymptomProcedures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://www.meddra.org 10031285}">Osteoporose postmenopausal</span></td></tr></table><h3>IntendedEffects</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://spor.ema.europa.eu/v1/lists/200000003186 200000003192}">preventive</span></td></tr></table></blockquote></div>
        </text>
        <type value="indication"/>
        <subject>
          <reference value="MedicinalProductDefinition/Estalis-Transdermalpatch"/>
        </subject>
        <indication>
          <diseaseSymptomProcedure>
            <concept>
              <coding>
                <system value="https://www.meddra.org"/>
                <code value="10031285"/>
                <display value="Osteoporose postmenopausal"/>
              </coding>
            </concept>
          </diseaseSymptomProcedure>
          <intendedEffect>
            <concept>
              <coding>
                <system value="http://spor.ema.europa.eu/v1/lists/200000003186"/>
                <code value="200000003192"/>
                <display value="preventive"/>
              </coding>
            </concept>
          </intendedEffect>
        </indication>
      </ClinicalUseDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPIngredient/Estradiol-hemihydrate-0.512mg"/>
    <resource>
      <Ingredient>
        <id value="Estradiol-hemihydrate-0.512mg"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-ingredient"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Estradiol-hemihydrate-0.512mg"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Estradiol-hemihydrate-0.512mg</b></p><a name="Estradiol-hemihydrate-0.512mg"> </a><a name="hcEstradiol-hemihydrate-0.512mg"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-ingredient.html">IDMP Ingredient</a></p></div><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="AdministrableProductDefinition-PhP-Estradiolum-Norethisteroni-Transdermalpatch.html">AdministrableProductDefinition: status = active; administrableDoseForm = Transdermal patch; unitOfPresentation = Patch</a></li><li><a href="ManufacturedItemDefinition-MI-Estradiolum-Norethisteroni-Transdermalpatch.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Transdermal patch; unitOfPresentation = Patch</a></li></ul><p><b>role</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-ingredient-role 756005051001}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-substance CXY7B3Q98Z}">Estradiol-hemihydrate</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td></tr><tr><td style="display: none">*</td><td>0.512 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM  codemg = 'mg')</span>/1 Patch<span style="background: LightGoldenRodYellow"> (Details: EDQM - Standard Terms  code15036000 = 'Patch')</span></td></tr></table></blockquote></div>
        </text>
        <status value="active"/>
        <for>
          <reference value="AdministrableProductDefinition/PhP-Estradiolum-Norethisteroni-Transdermalpatch"/>
        </for>
        <for>
          <reference value="ManufacturedItemDefinition/MI-Estradiolum-Norethisteroni-Transdermalpatch"/>
        </for>
        <role>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-ingredient-role"/>
            <code value="756005051001"/>
            <display value="Active"/>
          </coding>
        </role>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-substance"/>
                <code value="CXY7B3Q98Z"/>
                <display value="Estradiol-hemihydrate"/>
              </coding>
            </concept>
          </code>
          <strength>
            <presentationRatio>
              <numerator>
                <value value="0.512"/>
                <unit value="mg"/>
                <system value="http://unitsofmeasure.org"/>
                <code value="mg"/>
              </numerator>
              <denominator>
                <value value="1"/>
                <unit value="Patch"/>
                <system value="http://standardterms.edqm.eu"/>
                <code value="15036000"/>
              </denominator>
            </presentationRatio>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://fhir.epl.bag.admin.ch/CHIDMPIngredient/Norethisteroni-acetas-0.496mg"/>
    <resource>
      <Ingredient>
        <id value="Norethisteroni-acetas-0.496mg"/>
        <meta>
          <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-ingredient"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Norethisteroni-acetas-0.496mg"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Norethisteroni-acetas-0.496mg</b></p><a name="Norethisteroni-acetas-0.496mg"> </a><a name="hcNorethisteroni-acetas-0.496mg"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-ingredient.html">IDMP Ingredient</a></p></div><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="AdministrableProductDefinition-PhP-Estradiolum-Norethisteroni-Transdermalpatch.html">AdministrableProductDefinition: status = active; administrableDoseForm = Transdermal patch; unitOfPresentation = Patch</a></li><li><a href="ManufacturedItemDefinition-MI-Estradiolum-Norethisteroni-Transdermalpatch.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Transdermal patch; unitOfPresentation = Patch</a></li></ul><p><b>role</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-ingredient-role 756005051001}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-substance 9S44LIC7OJ}">Norethisterone acetate</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td></tr><tr><td style="display: none">*</td><td>0.496 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM  codemg = 'mg')</span>/1 Patch<span style="background: LightGoldenRodYellow"> (Details: EDQM - Standard Terms  code15036000 = 'Patch')</span></td></tr></table></blockquote></div>
        </text>
        <status value="active"/>
        <for>
          <reference value="AdministrableProductDefinition/PhP-Estradiolum-Norethisteroni-Transdermalpatch"/>
        </for>
        <for>
          <reference value="ManufacturedItemDefinition/MI-Estradiolum-Norethisteroni-Transdermalpatch"/>
        </for>
        <role>
          <coding>
            <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-ingredient-role"/>
            <code value="756005051001"/>
            <display value="Active"/>
          </coding>
        </role>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-substance"/>
                <code value="9S44LIC7OJ"/>
                <display value="Norethisterone acetate"/>
              </coding>
            </concept>
          </code>
          <strength>
            <presentationRatio>
              <numerator>
                <value value="0.496"/>
                <unit value="mg"/>
                <system value="http://unitsofmeasure.org"/>
                <code value="mg"/>
              </numerator>
              <denominator>
                <value value="1"/>
                <unit value="Patch"/>
                <system value="http://standardterms.edqm.eu"/>
                <code value="15036000"/>
              </denominator>
            </presentationRatio>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
</Bundle>